openPR Logo
Press release

Cancer Biomarkers Market - Analysis And Forecast (2016-2024): Market Shares And Strategies Of Key Players

04-20-2017 07:58 PM CET | Health & Medicine

Press release from: Cancer Biomarkers Market

Cancer Biomarkers Market - Analysis And Forecast (2016-2024):

Cancer is the second-leading cause of death worldwide (World Health Organization). There were around 14 million new cases of cancer reported across the globe in 2012 and the incidence rate is expected to increase by around 70% by 2030 (WHO). The most common cancer types are lung cancer, liver cancer, colorectal cancer, stomach cancer, and breast cancer.

Download Exclusive PDF Brochure of This Report : https://www.coherentmarketinsights.com/insight/request-sample/175

Cancer therapies are expensive and the cost rises with increase in complexity or stage of the caner condition. Therefore, understanding cancer biomarkers is the key to developing the right treatment plan for a cancer patient. Biomarkers indicates one’s health condition and the underlying disease condition. Various types of biomolecules such as DNA, proteins, and hormones are widely used to detect the malady. These biomarkers can be found in blood, urine, stool, tumor tissue, or other body fluids. Different cancer biomarkers react differently to various cancer treatments. There are increasing efforts to diagnose cancer at an early stage, which would drive the global cancer biomarkers market growth. However, poor reimbursement policies is negatively impacting market growth.

Cancer Biomarkers Market Taxonomy

The global cancer biomarkers market can be segmented on the basis of biomarker type, cancer type, application, and biomarker profiling technologies. On the basis of biomarker type, the market is segmented into protein biomarker, genetic biomarker and cellular biomarkers, and others.

Get Exclusive Discount on this CMI Report: https://www.coherentmarketinsights.com/insight/request-discount/175

On the basis of cancer type, the global caner biomarkers market is segmented into lung cancer, breast cancer, prostate cancer, cervical cancer, colorectal cancer and others. Human epidermal growth factor receptor 2 (HER2) is the biomarker highly targeted for breast cancer treatment. Other types of cancer biomarkers include ERCC1, BRCA1, BRCA2 and SPARC.

On the basis of profiling technology, the market is segmented into omics technologies, imaging technologies, immunoassays, cytogenetic based tests, and bioinformatics. Omics technologies is widely used profiling technology in the global market. Growing demand for personalized treatment therapies, use of proteomics in cancer biomarker detection, growing demand for accurate & effective diagnostic procedures are amongst the major factors driving its market growth. Enzyme-Linked Immunosorbent Assay (ELISA) is the most widely used immunoassays profiling technology in the global cancer biomarkers industry.

On the basis of application, the market is classified as drug discovery and development, diagnostics, prognostics, risk assessment and others. Cancer biomarkers are finding increasing applications in drug discovery with growing research activities on targeted cancer therapies.

Cancer Biomarkers Market: Regional Overview

North America and Europe dominate the global cancer biomarkers market on account of high cancer diagnostic and detection procedures, high investment in research and development by pharmaceutical and biotechnology companies and better healthcare infrastructure supporting the R&D activities using biomarkers. Markets in emerging economies such as the Asia Pacific and Latin America are poised to grow at a considerable higher growth rate owing to increasing funding for cancer biomarker research, growing prevalence of cancer, increasing number of clinical trials and growing demand for targeted and personalized drug therapies. The WHO estimates that in 2015 only 35% of the low-income countries reported to have pathology services available in the public sector. The rate is extremely less compared the high-income countries, which reported 90% availability of pathology services. These factors highly govern the growth of cancer biomarkers market, as accessibility would enable uptake of this technology by the users.

Browse Global Strategic Business Report : https://www.coherentmarketinsights.com/ongoing-insight/cancer-biomarkers-market-175

Some of the key players in the global cancer biomarkers market include Abbott Laboratories, Merck & Co. Inc., Affymetrix Inc., Agilent Technologies, Illumina, Inc., Roche Diagnostics Ltd, Becton Dickinson and Company, Thermo Fisher Scientific Inc., Qiagen NV, and Hologic Inc.

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com
Visit Coherent Market Insights Blog @ https://blog.coherentmarketinsights.com/
Connect with us on LinkedIn @ https://www.linkedin.com/company/coherent-market-insights

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Cancer Biomarkers Market - Analysis And Forecast (2016-2024): Market Shares And Strategies Of Key Players here

News-ID: 509214 • Views:

More Releases from Cancer Biomarkers Market

Global Cancer Biomarkers Market - Key Players involved in the research Such As Abbott Laboratories, Thermo Fisher Scientific Inc., Illumina, Inc. and Agilent Technologies
Global Cancer Biomarkers Market - Key Players involved in the research Such As A …
Researchmoz added Most up-to-date research on "Global Cancer Biomarkers Market - Key Players involved in the research Such As Abbott Laboratories, Thermo Fisher Scientific Inc., Illumina, Inc. and Agilent Technologies" to its huge collection of research reports. Biomarkers are the substance or molecules found in blood, other body fluids or tissues which states the normal and abnormal condition of the body, biomarkers helps to detect various diseases such as cancer. Cancer
Global Cancer Biomarkers Market to 2025| Abbott Laboratories, Thermo Fisher Scientific, F Hoffmann-La Roche, Illumina, Agilent Technologies, QIAGEN, Merck & Co, Hologic, Novartis AG, bioMérieux SA, Genomic Health
Global Cancer Biomarkers Market to 2025| Abbott Laboratories, Thermo Fisher Scie …
Albany, NY, 8th January : Recent research and the current scenario as well as future market potential of "Cancer Biomarkers Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025" globally. Global Cancer Biomarkers Market: Overview Biomarkers are the substance or molecules found in blood, other body fluids or tissues which states the normal and abnormal condition of the body, biomarkers helps to detect various diseases
Cancer Biomarkers Market : Industry Trends, Manufacturing Process, Machinery, Raw Materials, Cost and Revenue 2017-2025
Cancer Biomarkers Market : Industry Trends, Manufacturing Process, Machinery, Ra …
Researchmoz added Most up-to-date research on "Cancer Biomarkers Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025" to its huge collection of research reports. Global Cancer Biomarkers Market: Overview Biomarkers are the substance or molecules found in blood, other body fluids or tissues which states the normal and abnormal condition of the body, biomarkers helps to detect various diseases such as cancer. Cancer biomarkers tests
CANCER BIOMARKERS MARKET - GLOBAL INDUSTRY INSIGHTS, TRENDS, OUTLOOK, AND OPPORTUNITY ANALYSIS, 2016–2024
CANCER BIOMARKERS MARKET - GLOBAL INDUSTRY INSIGHTS, TRENDS, OUTLOOK, AND OPPORT …
Cancer is the second-leading cause of death worldwide (World Health Organization). There were around 14 million new cases of cancer reported across the globe in 2012 and the incidence rate is expected to increase by around 70% by 2030 (WHO). The most common cancer types are lung cancer, liver cancer, colorectal cancer, stomach cancer, and breast cancer. Get PDF Research Brochure for more Professional and Technical Insights: https://www.coherentmarketinsights.com/insight/request-sample/175 Cancer therapies are expensive

All 5 Releases


More Releases for Coherent

Surge In Air Traffic Boosts Demand For Advanced Coherent Radar Systems: Pivotal …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. Coherent Radar Market Size Growth Forecast: What to Expect by 2025? In recent times, the coherent radar market has demonstrated potent growth. It is anticipated to expand from $8.18 billion in 2024 to $8.97 billion in 2025, boasting a compound annual growth rate (CAGR) of 9.8%. The historic growth
Coherent Radar Market Analysis and Opportunities 2024
"The Business Research Company recently released a comprehensive report on the Global Coherent Radar Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry. According to The Business Research Company's, The coherent radar market size
Optogenetics Market to Witness Stunning Growth | Coherent, Addgene, Bruker
The latest study released on the Global Optogenetics Market by HTF MI Research evaluates market size, trend, and forecast to 2029. The Optogenetics market study covers significant research data and proofs to be a handy resource document for managers, analysts, industry experts and other key people to have ready-to-access and self-analyzed study to help understand market trends, growth drivers, opportunities and upcoming challenges and about the competitors. Key Players in This
Immobilized Trypsin Market Report 2021 - Coherent Market Insights
Immobilized Trypsin Market is created in this intelligence report. This comprehensive research report is a well-thought-out compilation of detailed market development and growth factors optimizing the path of continued growth in terms of exact product data, strategies, and market share of the leading companies in this particular market. We follow an iterative model of research methodology to formulate the report that helps decision-makers make an informed investment appraisal. Literature research
Bioinformatics Market Outlook Till, 2027 : Coherent Market Insights
The Bioinformatics Market report gives a weighty source to assess the market and other fundamental technicalities identifying with it. The examination unveils the total assessment and veritable parts of the Bioinformatics Market. The research analysts provide an elaborate description of the value chain and its distributor analysis. This Market study provides comprehensive data which enhances the understanding, scope and application of this report.The trends and expected prospects for the market
AI App Development || Coherent Lab LLP
The IT industry is growing day by day and immense popularity. Nowadays, businesses are in search of better opportunities to make money in more innovative way. Considering the AI (artificial intelligence) in mobile and web app development, we at Coherent Lab LLP focuses on developing practical solutions which streamlines to generate more and more profits and smoothen the operations as well. Situated in the heart of pinkcity, Jaipur, Coherent Lab